Week in Geek Podcast: A $9B biotech deal and a look at Pittsburgh’s tech renaissance

Juno CEO Hans Bishop (left) speaking to VP of Research and Receptor Discovery Francois Vigneault inside his lab. (GeekWire Photo / Kurt Schlosser)

GeekWire is going to Pittsburgh to cover the city’s tech renaissance, the challenges it faces as it grows and the dynamic in the city as it vies for Amazon’s HQ2. Hear what we’re looking forward to seeing and learning in the Steel City on this episode of the Week In Geek.

Plus, one of Seattle’s most promising biotech companies is bought by Celgene for $9 billion. Why does the city have such a hard time hanging on to biotechs?

All that and more on this episode of The Week In Geek, our weekly news roundup and analysis podcast. Listen in the player below or subscribe to the show in Apple Podcasts, Overcast, Stitcher or your favorite podcast app.

This week’s stories:

  • Juno Therapeutics acquired by Celgene for $9B in dramatic deal for rising biotech star

  • Why Celgene decided to buy Juno Therapeutics for $9B — with a little help from U.S. tax reform

  • Pittsburgh forges a new future, remaking iconic steel town into a modern innovation factory